Parents who returned the questionnaire were sent a consent form and a kit to collect oral fluid, with clear instructions on how to obtain a sample

from their child, which they were asked to return to the Health Protection Agency (HPA). Approximately 7000 introductory letters were distributed by schools; 550 questionnaires were returned with a positive history of chickenpox, 84 with a negative history, and 56 with an uncertain history, and 1 was incomplete. We posted 268 oral fluid kits, including 128 to respondents with a positive history of chickenpox and all those with negative or uncertain histories. Families were informed at the outset in the initial study information pack that, as a token of appreciation, a voucher for £10 would be sent to them once a sample was received in the laboratory. Children found to be susceptible to varicella were offered two doses of varicella vaccine ERK inhibitor without charge. Oral fluid samples and consent forms were received by the HPA Virus Reference Department, MS-Colindale, and processed to extract VZV-IgG using standard methods and diluents. Oral fluid samples were stored at −30 °C prior to batch testing. For semi-quantitative determination of IgG antibodies to VZV, the in-house VZV-IgG time resolved fluorescence immunoassay, (TRFIA), [12] was modified for testing oral fluid. Testing of paired serum and oral fluid samples, had previously established that measurements above a cut-off of 0.35 mIU/mL should

be considered positive, below a cut-off of 0.25 mIU/mL as negative, with an equivocal range between 0.25 and 0.35 mIU/mL. [HPA unpublished data] RGFP966 Samples testing negative or equivocal were also tested for total IgG to determine whether the sample had been taken appropriately and contained sufficient total IgG, using a cut-off of greater than 2.5 mg/L. Data were analysed using Stata v12 (Statcorp, TX, US). For each chickenpox history group, we aimed for a sample size of 100, to estimate with reasonable precision

the proportion with VZV-IgG (95% confidence interval within ±10%). The study was not designed or powered to detect differences by ethnicity. Exact 95% confidence intervals for proportions were calculated and proportions compared according to history using two-sided Dipeptidyl peptidase Fisher’s exact tests. We also undertook a sensitivity analysis to investigate the impact of using the oral fluid assay in populations with different VZV-IgG prevalence by modelling the effect of different values for the negative predictive value (NPV) of the assay. 120 oral fluid samples were received from respondents with a positive history of chickenpox, 77 with a negative history and 50 with an uncertain history. The average age of respondents was 13 years, and 85% were white, 6% mixed ethnicity, 6% Asian, 3% Black, and 1% Chinese. The groups with different history responses were not significantly different with respect to age or ethnicity (data not shown). Overall, 109 (90.8% [95% CI 85.